The concentrator was returned to invacare.Through visual inspection, it was confirmed that the unit exhibited evidence that the product tank cap had experienced an over-pressurization event.It was observed that the product tank cap was fragmented, there was deformation to the sound box and an indentation of the cabinet near where the product tank was positioned, and the front and rear shrouds had begun to separate.In addition to the damage sustained at the product tank, it was observed that the tubing connected to the pe valve and check valves sustained discoloration, and there was sieve material present within the tubing.This incident is being reported to the fda out of an abundance of caution, based on the evidence from the evaluation that the product tank experienced an over-pressurization event.This failure mode has been previously identified and investigated.The investigation activities concluded that the failure is unlikely to occur when the system is operating under normal conditions or a single fault condition.Rather, the system likely has to experience multiple faults to result in the failure observed.Even though the failure is unlikely to occur, components of the irc5po2v concentrator have been updated to prevent potential recurrence of this issue.The subject concentrator was manufactured prior to implementation of these updates.
|